I'm not fully conversant with all of that, but I can say that for the neurological study that was done, with 19 different studies on the neurological diseases, all of the groups came together to look at the expectations and at what the future would be for many of them. For example, with Parkinson's, by the year 2030 there will be over 135,000 people with the disease. I think that's part of the key.
The longitudinal study is really looking at how people are impacted over a period of time. I was involved in a microsimulation where we actually were asked, from the time of diagnosis to ultimately the time when somebody passed, what were the implications, what were the changes in life, and what were the behaviours and everything else. I think we work very closely together.
To pick up on research, in our national research program for Parkinson Society Canada, all of our researchers work collectively together. I've seen significant increases in where we're going and how we're getting there for this particular disease. I can tell you that it's been very exciting. I would say on the record that we probably have some of the best Parkinson's researchers in the world working on this and collaborating with people around the world.
So I think there's a lot of collaboration going on. I expect that with this additional funding we're asking for, there will be even more work to be able to get to where we need to get.